Figitumumab (Anti-IGF1R / CD221)
Figitumumab (Anti-IGF1R / CD221) is a human monoclonal antibody directed against the insulin-like growth factor type I receptor (IGF1R) with potential antineoplastic activity. Figitumumab prevents IGF1 from binding to IGF1R with an IC50 of 1.8 nM. MW: 146.0 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2942 |
| Sku # | A2942-1mg*5 |
| Pricing | 1mg*5, $970.00 |